Anti-RNF139 monoclonal antibody

Pre-made anti-RNF139 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RNF139/RNF139 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1508-Ab-1/ GM-Tg-hg-IP1508-Ab-2Anti-Human RNF139 monoclonal antibodyHuman
GM-Tg-rg-IP1508-Ab-1/ GM-Tg-rg-IP1508-Ab-2Anti-Rat RNF139 monoclonal antibodyRat
GM-Tg-mg-IP1508-Ab-1/ GM-Tg-mg-IP1508-Ab-2Anti-Mouse RNF139 monoclonal antibodyMouse
GM-Tg-cynog-IP1508-Ab-1/ GM-Tg-cynog-IP1508-Ab-2Anti-Cynomolgus/ Rhesus macaque RNF139 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1508-Ab-1/ GM-Tg-felg-IP1508-Ab-2Anti-Feline RNF139 monoclonal antibodyFeline
GM-Tg-cang-IP1508-Ab-1/ GM-Tg-cang-IP1508-Ab-2Anti-Canine RNF139 monoclonal antibodyCanine
GM-Tg-bovg-IP1508-Ab-1/ GM-Tg-bovg-IP1508-Ab-2Anti-Bovine RNF139 monoclonal antibodyBovine
GM-Tg-equg-IP1508-Ab-1/ GM-Tg-equg-IP1508-Ab-2Anti-Equine RNF139 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1508-Ab-1/ GM-Tg-hg-IP1508-Ab-2; GM-Tg-rg-IP1508-Ab-1/ GM-Tg-rg-IP1508-Ab-2;
GM-Tg-mg-IP1508-Ab-1/ GM-Tg-mg-IP1508-Ab-2; GM-Tg-cynog-IP1508-Ab-1/ GM-Tg-cynog-IP1508-Ab-2;
GM-Tg-felg-IP1508-Ab-1/ GM-Tg-felg-IP1508-Ab-2; GM-Tg-cang-IP1508-Ab-1/ GM-Tg-cang-IP1508-Ab-2;
GM-Tg-bovg-IP1508-Ab-1/ GM-Tg-bovg-IP1508-Ab-2; GM-Tg-equg-IP1508-Ab-1/ GM-Tg-equg-IP1508-Ab-2
Products NameAnti-RNF139 monoclonal antibody
Formatmab
Target NameRNF139
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RNF139 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1508-Ag-1Recombinant multi-species RN139/ RNF139/ HRCA1 protein


    Target information

    Target IDGM-IP1508
    Target NameRNF139
    Gene ID11236,75841,315000,706207,609422,101090488,788471,100067392
    Gene Symbol and Synonyms4930555P18Rik,HRCA1,RCA1,RNF139,TRC8
    Uniprot AccessionQ8WU17
    Uniprot Entry NameRN139_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000170881
    Target ClassificationTumor-associated antigen (TAA)

    The target: RNF139, gene name: RNF139, also named as HRCA1, RCA1, TRC8. The protein encoded by this gene is a multi-membrane spanning protein containing a RING-H2 finger. This protein is located in the endoplasmic reticulum, and has been shown to possess ubiquitin ligase activity. This gene was found to be interrupted by a t(3:8) translocation in a family with hereditary renal and non-medulary thyroid cancer. Studies of the Drosophila counterpart suggested that this protein may interact with tumor suppressor protein VHL, as well as with  COPS5/JAB1, a protein responsible for the degradation of tumor suppressor CDKN1B/P27KIP. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.